The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Laplume Joseph W since 2019.
This trader's CIK number is 1767215.
At the time of last reporting, Laplume Joseph W was the EVP, Corp Strategy & Develop of Charles River Laboratories International, Inc.. (stock ticker symbol CRL).
Also see all insider trading activities at Charles River Laboratories International, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CRL | 0 | $0 | 1,200 | $186,096 | 0 | $0 |
| 2024 | CRL | 0 | $0 | 3,922 | $851,051 | 0 | $0 |
| 2023 | CRL | 0 | $0 | 12,982 | $2,350,219 | 9,128 | $1,320,547 |
| 2022 | CRL | 0 | $0 | 9,077 | $2,161,385 | 7,152 | $766,181 |
| 2021 | CRL | 0 | $0 | 12,435 | $3,956,453 | 2,750 | $242,137 |
| 2020 | CRL | 0 | $0 | 22,507 | $4,343,447 | 13,089 | $1,281,936 |
| 2019 | CRL | 0 | $0 | 12,958 | $1,786,554 | 11,588 | $1,007,460 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | CRL | Sale | 800 | 157.60 | 126,080 |
| 2025-08-07 | CRL | Sale | 400 | 150.04 | 60,016 |
| 2024-08-08 | CRL | Sale | 1,780 | 199.36 | 354,860 |
| 2024-05-10 | CRL | Sale | 1,304 | 226.97 | 295,968 |
| 2024-02-15 | CRL | Sale | 838 | 238.93 | 200,223 |
| 2023-11-30 | CRL | Sale | 1,850 | 197.73 | 365,800 |
| 2023-11-09 | CRL | Sale | 9,128 | 173.26 | 1,581,562 |
| 2023-11-09 | CRL | Option Ex | 9,128 | 144.67 | 1,320,547 |
| 2023-08-10 | CRL | Sale | 700 | 216.52 | 151,564 |
| 2023-05-15 | CRL | Sale | 345 | 190.39 | 65,684 |
| 2023-05-12 | CRL | Sale | 959 | 193.54 | 185,609 |
| 2022-12-01 | CRL | Sale | 6,409 | 224.11 | 1,436,295 |
| 2022-12-01 | CRL | Option Ex | 6,409 | 109.34 | 700,760 |
| 2022-11-04 | CRL | Sale | 534 | 216.36 | 115,536 |
| 2022-08-05 | CRL | Sale | 200 | 226.13 | 45,226 |
| 2022-02-23 | CRL | Sale | 395 | 292.75 | 115,636 |
| 2022-02-18 | CRL | Sale | 1,143 | 291.80 | 333,527 |
| 2022-02-22 | CRL | Sale | 396 | 290.82 | 115,165 |
| 2022-02-18 | CRL | Option Ex | 743 | 88.05 | 65,421 |
| 2021-08-06 | CRL | Sale | 3,700 | 403.60 | 1,493,323 |
| 2021-02-25 | CRL | Option Ex | 2,750 | 88.05 | 242,137 |
| 2021-02-25 | CRL | Sale | 8,735 | 281.98 | 2,463,130 |
| 2020-11-04 | CRL | Sale | 6,739 | 250.17 | 1,685,868 |
| 2020-11-04 | CRL | Option Ex | 6,739 | 114.02 | 768,380 |
| 2020-05-15 | CRL | Option Ex | 6,350 | 80.88 | 513,556 |
| 2020-05-15 | CRL | Sale | 15,418 | 168.40 | 2,596,452 |
| 2020-05-18 | CRL | Sale | 350 | 174.65 | 61,127 |
| 2019-03-08 | CRL | Option Ex | 11,588 | 86.94 | 1,007,460 |
| 2019-03-08 | CRL | Sale | 5,522 | 137.62 | 759,965 |
| 2019-03-08 | CRL | Sale | 5,770 | 138.00 | 796,283 |
| 2019-03-08 | CRL | Sale | 1,666 | 138.24 | 230,306 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laplume Joseph W (EVP, Corp Strategy & Develop of Charles River Laboratories International, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.